Results 141 to 150 of about 98,172 (269)

Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells. [PDF]

Mol Cancer
Zeng C, Nie D, Wang X, Zhong S, Zeng X, Liu X, Qiu K, Peng X, Zhang W, Chen S, Zha X, Chen C, Chen Z, Wang W, Li Y.   +14 more
europepmc   +1 more source

Specific human cellular immunity to bcr-abl oncogene-derived peptides

, 1996
Monica Bocchia, Tatyana Korontsvit, Qin Xu, Stephen Mackinnon, Shang‐You Yang, Alessandro Sette, DA Scheinberg   +6 more
openalex   +1 more source

Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms. [PDF]

Transl Oncol
Guo X, Jia W, Yang X, Jia H, Wu H, Wei Y, Can C, He N, Zhang H, Liu W, Yu S, Ma D.   +11 more
europepmc   +1 more source

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. [PDF]

Colomb Med (Cali), 2023
Giraldo-Rincón AI, Naranjo Molina S, Gomez-Lopera N, Aguirre Acevedo D, Ucroz Benavidez A, Gálvez Cárdenas K, Cuellar Ambrosí F, Cuellar Ambrosí F, Torres JD, Ospina S, Palacio K, Gaviria Jaramillo L, Muñeton CM, Vasquez Palacio G.   +13 more
europepmc   +1 more source

Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate [PDF]

, 2000
Takumi Era, Owen N. Witte
openalex   +1 more source

Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia

Autophagy, 2015
Xian Zeng, Hui Zhao, Yubin Li, Jiajun Fan, Yun Sun, Shao-Kai Wang, Ziyu Wang, P. Song, D. Ju   +8 more
semanticscholar   +1 more source

GPX1 confers resistance to metabolic stress in BCR/ABL-T315I mutant chronic myeloid leukemia cells. [PDF]

Cell Death Discov
Wang JD, Wang JX, Lin ZL, Xu N, Zhang L, Liu JJ, Gao R, Long ZJ.   +7 more
europepmc   +1 more source

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.

Cancer Cell, 2009
T. O'hare, W. Shakespeare, Xiaotian Zhu, C. Eide, V. Rivera, Frank Y. Wang, Lauren T. Adrian, Tianjun Zhou, Wei-sheng Huang, Qihong Xu, C. Metcalf, J. Tyner, M. Loriaux, A. Corbin, Scott D. Wardwell, Y. Ning, J. Keats, Yihan Wang, R. Sundaramoorthi, Mathew P. Thomas, Dong Zhou, Joseph T Snodgrass, L. Commodore, T. Sawyer, D. Dalgarno, M. Deininger, B. Druker, T. Clackson   +27 more
semanticscholar   +1 more source

Correction to "Molecular Modeling of Single- and Double-Hydrocarbon-Stapled Coiled-Coil Inhibitors against Bcr-Abl: Toward a Treatment Strategy for CML". [PDF]

J Phys Chem B
Carolina P Lima M, Hornsby BD, Lim CS, Cheatham TE.   +3 more
europepmc   +1 more source

3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib. [PDF]

Pharmaceuticals (Basel)
Cabezas D, Delgado T, Sepúlveda G, Krňávková P, Vojáčková V, Kryštof V, Strnad M, Silva NI, Echeverría J, Espinosa-Bustos C, Mellado G, Luo J, Mella J, Salas CO.   +13 more
europepmc   +1 more source